CategoriesGLP-1 Weight Loss Medications Weight Loss & Fitness

The Miracle That Costs You Your Health

Unlicensed Weight Loss Drugs

Why this market exists at all

The demand for weight loss medication has never been higher. Treatments such as Mounjaro and Wegovy have transformed medical weight loss for many people, but they’ve also created a growing market for unlicensed medicines and unregulated online sellers looking to profit.

 

That difference explains everything else. A registered clinician is bound by regulators, carries legal responsibility for your safety, and has nothing to gain from cutting corners. An anonymous online seller has none of those duties, and every reason to tell you what you want to hear.

The risks of buying unlicensed weight loss medication

The clearest example right now is retatrutide. You will see it everywhere online, photographed in a pen beside dramatic before-and-after images. What those posts leave out is simple: retatrutide is still in clinical trials. It has not been approved by the UK regulator, the MHRA, and under the Human Medicines Regulations 2012 it is illegal to sell or supply for human use here. The only lawful way to access it is inside an approved trial.

 

“Illegal” can sound like a technicality. The harm is not. In late 2025 the MHRA raided the first illicit weight-loss-drug factory ever found in the UK, seizing more than two thousand unlicensed retatrutide and tirzepatide pens ready to post to customers. A second site was shut down months later. The regulator’s verdict was blunt: untested, unauthorised and potentially deadly, because nobody knows what is inside them. Too much active drug, too little, the wrong drug, or substances that should never go near a human body.

 

This is not theoretical. Falsified pens sold in the UK have been confirmed to contain insulin instead of the labelled medicine. For someone without diabetes, that can cause dangerously low blood sugar, and people have been hospitalised in hypoglycaemic shock as a result. In one deeply sad case, a woman in her fifties died after being given a weight-loss injection in a non-clinical setting. These are the outcomes the glossy posts never show you.

The “peptide” and “longevity” trend

The same pattern is repeating with so-called peptides, marketed for weight loss, muscle, anti-ageing and “longevity.” It is worth being precise here, because the marketing relies on confusion.

 

No peptide sold for weight loss or longevity holds a UK marketing authorisation. Compounds like NMN, often mentioned alongside NAD⁺, are not licensed medicines at all. They sit under food-supplement law as “novel foods” still being assessed by the Food Standards Agency, and cannot lawfully claim to treat, prevent or cure anything. A “research use only” or “not for human consumption” label is not a reassurance. It is a legal trick to sidestep medicines law, and it tells you the seller knows the product is not authorised for you.

 

If a compound really worked as safely and dramatically as its sellers claim, it would be going through the same approval process as every licensed medicine. There is usually one reason it has not: it has not yet been proven safe.

Even licensed medicines can be used dangerously

Here is the part that surprises people most. The danger is not only about unlicensed drugs. It is just as real when untrained voices online tell you to misuse a licensed one.

 

You will see influencers telling you to go “off-licence”: microdosing, stretching your supply, or chasing a so-called “golden dose,” all ways of using a medicine as its manufacturer never tested it. A licence is not red tape. It is the exact set of conditions under which the drug was studied and shown to be safe. Step outside them and you are running an experiment on yourself, guided by someone with no clinical training, no accountability, and a real talent for being unreachable the moment things go wrong.

 

Prescription-only medicines are classed that way for good reason. They act powerfully on the body, and they need a proper assessment of your health, your history and your other medicines before anyone prescribes them. I have taken this class of medicine myself, so I understand why a shortcut is tempting. That is exactly why the people selling them do so well. But only a registered clinician can weigh all of this and decide what is right for you. A GLP-1 medicine is not a protein shake or a meal-replacement bar, and should never be treated like one.

The new pill, and the misuse that is coming

Oral semaglutide, the Wegovy pill, is now available. Expect a fresh wave of bad advice. Someone will almost certainly tell you to split or crush the tablet to make it last longer. Please do not.

 

Oral semaglutide is absorbed in an unusual way. It is paired with an absorption enhancer called SNAC. And yes, somewhere a scientist decided the ingredient that helps a weight-loss drug work should be called a SNAC, which I choose to believe was on purpose. SNAC creates a small protected pocket in the stomach that shields the medicine from being broken down and lets it absorb there. That mechanism is delicate. Crush, chew or split the tablet and you destroy it, wasting the dose. Splitting fails on simple maths too: the medicine is not absorbed in a straight line, so two smaller tablets do not equal one larger dose.

 

This is why the instructions are so specific, and why they are worth following to the letter:

  • Take it first thing in the morning, on an empty stomach, after an overnight fast.
  • Swallow it whole with no more than 120 ml of plain water, about half a glass. Only plain water. A larger volume actually lowers how much medicine you absorb.
  • Wait at least 30 minutes before you eat, drink anything else, or take other medicines.

 

Follow them and the medicine works as it should. Ignore the person online telling you to “make it stretch,” and you protect your health and your money.

What safe actually looks like

None of this means weight loss medication should be feared. When prescribed appropriately as part of a clinician-led weight management programme, treatments like Mounjaro and Wegovy can be safe and effective. The key is making sure you’re receiving genuine medication from qualified healthcare professionals who are regulated and accountable.

Before you trust anyone with your health, check three things:

  • The prescriber is a registered UK clinician who assesses you properly first.
  • The pharmacy is registered with the General Pharmaceutical Council (GPhC). You can check this yourself on the GPhC register.
  • The medicine is licensed in the UK for the reason you are taking it.

If a seller cannot meet all three, that low price is not a bargain. Don’t get me wrong, I love a bargain as much as anyone, and I will happily spend far too long hunting one down. I just draw the line at bargain-hunting with my own health, because it is the one purchase where the discount can cost you everything. The people who pay that price are never the ones who made the profit.

 

If you have already bought or used a product from an unregulated source and feel unwell, please speak to a clinician. You can also report a suspected falsified or unlicensed medicine to the MHRA through its Yellow Card scheme at yellowcard.mhra.gov.uk.

 

Your health is worth more than a shortcut. If something feels too good to be true, it probably is. Choosing a regulated provider means you’re not just paying for medication. You’re paying for the clinical expertise, ongoing support and safety checks that help ensure your treatment is both safe and effective.

 

That’s something no bargain can replace.

 

This article is for general information and does not replace personalised medical advice. If you have any questions about your treatment, the Envigore Patient Care team is here to help.

 

Book a Consultation

+ References
  1. Medicines and Healthcare products Regulatory Agency (2025) MHRA smashes major illicit weight-loss medicine production facility in record seizure. GOV.UK.
  2. Medicines and Healthcare products Regulatory Agency (2023) Ozempic (semaglutide) and Saxenda (liraglutide): vigilance required due to potentially harmful falsified products. Drug Safety Update, GOV.UK.
  3. World Health Organization (2024) Medical Product Alert No. 2/2024: falsified Ozempic (semaglutide).
  4. UK Parliament Health and Social Care Committee (2025) Written evidence on falsified and compounded GLP-1 medicines (reporting FDA data on compounded semaglutide harm).
  5. Food Standards Agency (2025) Regulated products and Novel Foods register, nicotinamide mononucleotide (NMN) status.
  6. Novo Nordisk / electronic Medicines Compendium (2026) Oral semaglutide: Summary of Product Characteristics and Patient Information Leaflet, administration and SNAC absorption.

About Your Clinical Team

This content was medically reviewed and approved by Danny Gian Hou Chu, a HCPC-Registered Physician Associate (PA38670), who oversees all prescribing decisions at Envigore.

 

All prescriptions are dispensed by Right Medicine Pharmacy, a GPhC-Registered Pharmacy (No. 9012382).

 

Nutritional guidance and lifestyle support are provided by Veronica Giudice, an HCPC-Registered Dietitian (DT26570) and British Dietetic Association member.

 

Last medically reviewed: June 2026

Leave a Reply

Your email address will not be published. Required fields are marked *